Jane Cronst, Lucas Prediger, Marcelo Abreu Pinto, Julia Ferraz, Angelo Zamban de Mattos, Mario Reis Alvares-DA-Silva, Cleber Rosito Pinto Kruel, Marcio Fernandes Chedid
{"title":"肝移植治疗急性-慢性肝功能衰竭的预后因素。","authors":"Jane Cronst, Lucas Prediger, Marcelo Abreu Pinto, Julia Ferraz, Angelo Zamban de Mattos, Mario Reis Alvares-DA-Silva, Cleber Rosito Pinto Kruel, Marcio Fernandes Chedid","doi":"10.1590/0102-672020230061e1779","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Liver transplantation (LT) is the only treatment that can provide long-term survival for patients with acute-on-chronic liver failure (ACLF). Although several studies identify prognostic factors for patients in ACLF who do not undergo LT, there is scarce literature about prognostic factors after LT in this population.</p><p><strong>Aim: </strong>Evaluate outcomes of ACLF patients undergoing LT, studying prognostic factors related to 1-year and 90 days post-LT.</p><p><strong>Methods: </strong>Patients with ACLF undergoing LT between January 2005 and April 2021 were included. Variables such as chronic liver failure consortium (CLIF-C) ACLF values and ACLF grades were compared with the outcomes.</p><p><strong>Results: </strong>The ACLF survival of patients (n=25) post-LT at 90 days, 1, 3, 5 and 7 years, was 80, 76, 59.5, 54.1 and 54.1% versus 86.3, 79.4, 72.6, 66.5 and 61.2% for patients undergoing LT for other indications (n=344), (p=0.525). There was no statistical difference for mortality at 01 year and 90 days among patients with the three ACLF grades (ACLF-1 vs. ACLF-2 vs. ACLF-3) undergoing LT, as well as when compared to non-ACLF patients. CLIF-C ACLF score was not related to death outcomes. None of the other studied variables proved to be independent predictors of mortality at 90 days, 1 year, or overall.</p><p><strong>Conclusions: </strong>LT conferred long-term survival to most transplant patients. None of the studied variables proved to be a prognostic factor associated with post-LT survival outcomes for patients with ACLF. Additional studies are recommended to clarify the prognostic factors of post-LT survival in patients with ACLF.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1779"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712924/pdf/","citationCount":"0","resultStr":"{\"title\":\"PROGNOSTIC FACTORS OF LIVER TRANSPLANTATION FOR ACUTE-ON-CHRONIC LIVER FAILURE.\",\"authors\":\"Jane Cronst, Lucas Prediger, Marcelo Abreu Pinto, Julia Ferraz, Angelo Zamban de Mattos, Mario Reis Alvares-DA-Silva, Cleber Rosito Pinto Kruel, Marcio Fernandes Chedid\",\"doi\":\"10.1590/0102-672020230061e1779\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Liver transplantation (LT) is the only treatment that can provide long-term survival for patients with acute-on-chronic liver failure (ACLF). Although several studies identify prognostic factors for patients in ACLF who do not undergo LT, there is scarce literature about prognostic factors after LT in this population.</p><p><strong>Aim: </strong>Evaluate outcomes of ACLF patients undergoing LT, studying prognostic factors related to 1-year and 90 days post-LT.</p><p><strong>Methods: </strong>Patients with ACLF undergoing LT between January 2005 and April 2021 were included. Variables such as chronic liver failure consortium (CLIF-C) ACLF values and ACLF grades were compared with the outcomes.</p><p><strong>Results: </strong>The ACLF survival of patients (n=25) post-LT at 90 days, 1, 3, 5 and 7 years, was 80, 76, 59.5, 54.1 and 54.1% versus 86.3, 79.4, 72.6, 66.5 and 61.2% for patients undergoing LT for other indications (n=344), (p=0.525). There was no statistical difference for mortality at 01 year and 90 days among patients with the three ACLF grades (ACLF-1 vs. ACLF-2 vs. ACLF-3) undergoing LT, as well as when compared to non-ACLF patients. CLIF-C ACLF score was not related to death outcomes. None of the other studied variables proved to be independent predictors of mortality at 90 days, 1 year, or overall.</p><p><strong>Conclusions: </strong>LT conferred long-term survival to most transplant patients. None of the studied variables proved to be a prognostic factor associated with post-LT survival outcomes for patients with ACLF. Additional studies are recommended to clarify the prognostic factors of post-LT survival in patients with ACLF.</p>\",\"PeriodicalId\":72298,\"journal\":{\"name\":\"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery\",\"volume\":\"36 \",\"pages\":\"e1779\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712924/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1590/0102-672020230061e1779\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/0102-672020230061e1779","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:肝移植(LT)是唯一能为急性-慢性肝功能衰竭(ACLF)患者提供长期生存的治疗方法。目的:评估接受肝移植的急性慢性肝功能衰竭患者的预后,研究与肝移植后 1 年和 90 天相关的预后因素:方法:纳入2005年1月至2021年4月期间接受LT治疗的ACLF患者。方法:纳入2005年1月至2021年4月期间接受LT治疗的ACLF患者,将慢性肝衰竭联盟(CLIF-C)ACLF值和ACLF分级等变量与结果进行比较:LT后90天、1年、3年、5年和7年,患者(n=25)的ACLF存活率分别为80%、76%、59.5%、54.1%和54.1%,而因其他适应症接受LT治疗的患者(n=344)的ACLF存活率分别为86.3%、79.4%、72.6%、66.5%和61.2%(P=0.525)。与非 ACLF 患者相比,接受 LT 的三个 ACLF 等级(ACLF-1 vs. ACLF-2 vs. ACLF-3)患者在 01 年和 90 天的死亡率没有统计学差异。CLIF-C ACLF评分与死亡结果无关。所研究的其他变量均不能独立预测90天、1年或总体死亡率:结论:LT可使大多数移植患者长期存活。结论:对于大多数移植患者来说,LT可带来长期生存,但研究变量中没有一个被证明是与ACLF患者LT后生存结果相关的预后因素。建议开展更多研究,以明确前交叉韧带纤维化患者LT后存活的预后因素。
PROGNOSTIC FACTORS OF LIVER TRANSPLANTATION FOR ACUTE-ON-CHRONIC LIVER FAILURE.
Background: Liver transplantation (LT) is the only treatment that can provide long-term survival for patients with acute-on-chronic liver failure (ACLF). Although several studies identify prognostic factors for patients in ACLF who do not undergo LT, there is scarce literature about prognostic factors after LT in this population.
Aim: Evaluate outcomes of ACLF patients undergoing LT, studying prognostic factors related to 1-year and 90 days post-LT.
Methods: Patients with ACLF undergoing LT between January 2005 and April 2021 were included. Variables such as chronic liver failure consortium (CLIF-C) ACLF values and ACLF grades were compared with the outcomes.
Results: The ACLF survival of patients (n=25) post-LT at 90 days, 1, 3, 5 and 7 years, was 80, 76, 59.5, 54.1 and 54.1% versus 86.3, 79.4, 72.6, 66.5 and 61.2% for patients undergoing LT for other indications (n=344), (p=0.525). There was no statistical difference for mortality at 01 year and 90 days among patients with the three ACLF grades (ACLF-1 vs. ACLF-2 vs. ACLF-3) undergoing LT, as well as when compared to non-ACLF patients. CLIF-C ACLF score was not related to death outcomes. None of the other studied variables proved to be independent predictors of mortality at 90 days, 1 year, or overall.
Conclusions: LT conferred long-term survival to most transplant patients. None of the studied variables proved to be a prognostic factor associated with post-LT survival outcomes for patients with ACLF. Additional studies are recommended to clarify the prognostic factors of post-LT survival in patients with ACLF.